BioTelemetry, Inc.
BEAT
BEAT was delisted on the 8th of February, 2021.
211 hedge funds and large institutions have $885M invested in BioTelemetry, Inc. in 2017 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 79 increasing their positions, 71 reducing their positions, and 20 closing their positions.
85% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 20
74% more call options, than puts
Call options by funds: $14.1M | Put options by funds: $8.09M
11% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 71
8% more funds holding
Funds holding: 195 → 211 (+16)
5% more capital invested
Capital invested by funds: $840M → $885M (+$44.9M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$37.8M |
| 2 |
Bank of New York Mellon
New York
|
+$14M |
| 3 |
Millennium Management
New York
|
+$10.6M |
| 4 |
BlackRock
New York
|
+$8.57M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$6.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$12.6M |
| 2 |
CC
Cannell Capital
Alta,
Wyoming
|
-$7.79M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
-$7.1M |
| 4 |
MPAM
Monarch Partners Asset Management
Boston,
Massachusetts
|
-$6.52M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$5.58M |
BEAT Hedge Fund Activity: Q3 2017 in Review
211 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q3 2017, worth a combined $885M — up 5.3% from $840M a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new BEAT positions and 20 closed out — a net gain of 17 holders — while 79 added to existing stakes and 71 trimmed.
The largest buyer was Glenmede Trust, opening a new position worth an estimated $37.8M. The largest seller was Wellington Management Group, cutting an estimated $12.6M.
- 211 institutional investors held BioTelemetry, Inc. (BEAT) as of Q3 2017, up from 195 in Q2 2017.
- Funds reported $885M of BioTelemetry, Inc. stock for Q3 2017, up 5.3% quarter-over-quarter.
- 37 funds opened new BioTelemetry, Inc. positions in Q3 2017 and 20 closed out, a net change of +17 holders.
- The largest BioTelemetry, Inc. buyer in Q3 2017 was Glenmede Trust, an estimated $37.8M added.
- The largest BioTelemetry, Inc. seller in Q3 2017 was Wellington Management Group, an estimated $12.6M sold.
Based on aggregated 13F filings for Q3 2017.